Avantor Correlations
AVTR Stock | USD 21.06 0.02 0.1% |
The current 90-days correlation between Avantor and H B Fuller is 0.54 (i.e., Very weak diversification). The correlation of Avantor is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Avantor Correlation With Market
Very weak diversification
The correlation between Avantor and DJI is 0.49 (i.e., Very weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Avantor and DJI in the same portfolio, assuming nothing else is changed.
Avantor |
Moving together with Avantor Stock
0.68 | A | Agilent Technologies Sell-off Trend | PairCorr |
0.92 | ME | 23Andme Holding Upward Rally | PairCorr |
0.77 | VALN | Valneva SE ADR | PairCorr |
0.75 | DOMH | Dominari Holdings | PairCorr |
0.8 | DRMA | Dermata Therapeutics | PairCorr |
0.69 | DRRX | Durect | PairCorr |
0.9 | DTIL | Precision BioSciences | PairCorr |
0.86 | VINC | Vincerx Pharma | PairCorr |
0.8 | VIRX | Viracta Therapeutics | PairCorr |
0.74 | VRCA | Verrica Pharmaceuticals | PairCorr |
0.65 | CDTTW | Conduit Pharmaceuticals | PairCorr |
0.66 | VTGN | VistaGen Therapeutics | PairCorr |
Moving against Avantor Stock
0.79 | DRUG | Bright Minds Biosciences Trending | PairCorr |
0.73 | VCYT | Veracyte | PairCorr |
0.67 | VERA | Vera Therapeutics | PairCorr |
0.64 | VCEL | Vericel Corp Ord | PairCorr |
0.6 | VANI | Vivani Medical | PairCorr |
0.31 | DMAC | DiaMedica Therapeutics Trending | PairCorr |
0.84 | VRNA | Verona Pharma PLC | PairCorr |
0.8 | SABSW | SAB Biotherapeutics | PairCorr |
0.69 | DVAX | Dynavax Technologies | PairCorr |
0.45 | KTTAW | Pasithea Therapeutics | PairCorr |
0.41 | DSGN | Design Therapeutics | PairCorr |
0.33 | DYAI | Dyadic International | PairCorr |
0.87 | VYNE | Vyne Therapeutics | PairCorr |
0.86 | VSTM | Verastem Trending | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Avantor Stock performing well and Avantor Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Avantor's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
ASH | 1.08 | (0.31) | 0.00 | (0.17) | 0.00 | 1.87 | 10.48 | |||
FUL | 1.07 | (0.31) | 0.00 | (0.08) | 0.00 | 1.76 | 8.58 | |||
ESI | 1.29 | 0.01 | 0.01 | 0.14 | 1.35 | 3.77 | 11.53 | |||
BCPC | 1.09 | (0.07) | (0.04) | 0.07 | 1.32 | 2.54 | 8.32 | |||
AXTA | 1.22 | 0.07 | 0.05 | 0.19 | 1.22 | 2.81 | 10.92 | |||
AVNT | 1.39 | (0.11) | (0.01) | 0.06 | 1.53 | 2.92 | 8.03 | |||
KWR | 1.52 | (0.32) | 0.00 | (0.02) | 0.00 | 2.23 | 18.04 | |||
CBT | 1.28 | (0.11) | (0.01) | 0.06 | 1.38 | 2.88 | 10.87 | |||
SXT | 1.08 | (0.16) | (0.06) | 0.02 | 1.32 | 2.14 | 8.84 | |||
IOSP | 1.24 | (0.17) | (0.02) | 0.05 | 1.37 | 2.24 | 16.32 |
Avantor Corporate Management
Joseph Massaro | Independent Director | Profile | |
Christophe MBA | Executive AMEA | Profile | |
Lan Kang | Independent Director | Profile | |
Tanya Foxe | Executive Vice President - Global Operations and Supply Chain | Profile |